DACS
ZLAB icon

Dymon Asia Capital (Singapore)’s Zai Lab ZLAB Stock Holding History

Dymon Asia Capital (Singapore)’s Portfolio ZLAB Stock Details ZLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-15,000
Closed -$542K – 205
2025
Q1 		$542K Sell
15,000
-5,000
-25% -$154K 0.12% 103
2024
Q4 		$524K Buy
+20,000
New +$555K 0.12% 94

Other funds holding ZLAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Dymon Asia Capital (Singapore)'s ZLAB Position: Q2 2025 in Review

Dymon Asia Capital (Singapore) sold out of Zai Lab (ZLAB) in Q2 2025, closing a stake of 15,000 shares — an estimated $542K sold.

Dymon Asia Capital (Singapore) first reported a position in ZLAB in Q4 2024 and held it in 2 quarters. The position peaked at $542K in Q1 2025. 156 funds tracked by Wall St. Rank hold ZLAB as of Q2 2025.

  • Dymon Asia Capital (Singapore) reported no remaining Zai Lab position as of Q2 2025 after selling out during the quarter.
  • Dymon Asia Capital (Singapore) sold 15,000 Zai Lab shares in Q2 2025, an estimated $542K.
  • Dymon Asia Capital (Singapore) first reported a position in Zai Lab in Q4 2024 and held it in 2 quarters.
  • Dymon Asia Capital (Singapore)'s Zai Lab position peaked at $542K in Q1 2025.
  • 156 funds tracked by Wall St. Rank held Zai Lab as of Q2 2025.

Based on Dymon Asia Capital (Singapore)'s 13F filing for Q2 2025, filed 14 Aug 2025.